Org.nr 917 285 322 2023 → 2024 Year-over-year analysis

AESTMED AS: årsregnskap 2024 vs 2023

Shrank 29% on revenue, returned to profit

approved 2025-06-10; registry 2025-06-14; journal 2025 536218

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2024 with 2023 for AESTMED AS. Revenue 939.0k NOK → 670.6k NOK (-28.6%). Net result -219.4k NOK → +197.4k NOK. Equity 325.1k NOK → 462.5k NOK.

On the constructive side: operating result improved; turned profitable; equity strengthened. Pressures included: revenue fell.

Net constructive year on the published lines.

Scorecard

Revenue
939.0k NOK 670.6k NOK
-28.6%
Operating result
-210.1k NOK +227.6k NOK
+208.3%
Net result
-219.4k NOK +197.4k NOK
+190.0%
Equity
325.1k NOK 462.5k NOK
+42.3%
Cash
302.8k NOK 341.7k NOK
+12.9%
Total assets
492.9k NOK 825.4k NOK
+67.4%

What improved

  • ↑

    Operating result improved

    Operating result -210.1k NOK → +227.6k NOK (op. margin -22.4% → 33.9%). Calculated

  • ↑

    Turned profitable

    Net result flipped from a loss of 219.4k NOK to a profit of 197.4k NOK. Calculated

  • ↑

    Equity strengthened

    Book equity 325.1k NOK → 462.5k NOK (equity ratio 65.9% → 56.0%). Calculated

  • ↑

    Cash rose

    Bank deposits 302.8k NOK → 341.7k NOK (+12.9% YoY). Calculated

  • ↑

    Payroll decreased

    Salary cost 1.70m NOK → 955.5k NOK (181% → 142% of revenue). Calculated

What deteriorated

  • ↓

    Revenue fell

    Operating income / revenue moved from 939.0k NOK to 670.6k NOK (-28.6% YoY). Calculated